Cargando…
PPARγ in Neuroblastoma
Neuroblastoma (NB) is the most common extracranial tumor in children and accounts for around 15% of all paediatric oncology deaths. The treatment of NB includes surgery, chemotherapy, and radiotherapy. Unfortunately, most children with NB present with advanced disease, and more than 60% of patients...
Autores principales: | Peri, Alessandro, Cellai, Ilaria, Benvenuti, Susanna, Luciani, Paola, Baglioni, Silvana, Serio, Mario |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397449/ https://www.ncbi.nlm.nih.gov/pubmed/18528516 http://dx.doi.org/10.1155/2008/917815 |
Ejemplares similares
Ejemplares similares
-
Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006) -
Exendin-4 Induces Cell Adhesion and Differentiation and Counteracts the Invasive Potential of Human Neuroblastoma Cells
por: Luciani, Paola, et al.
Publicado: (2013) -
In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012) -
PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)